Who Paid My Doc
Rajesh Malik
Neonatal-Perinatal Medicine Canton, OH Medical Doctor
NPI 1518949304 CMS profile 341589
1320 Mercy Dr Nw, Canton, OH 44708
General payments
$13,722
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Rajesh Malik of Canton, OH is reported in the CMS Open Payments database as having received $13,722 across 67 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 97th percentile of Neonatal-Perinatal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $728 | 8 | |
| 2024 | General | $10,469 | 25 | |
| 2023 | General | $624 | 4 | |
| 2022 | General | $331 | 6 | |
| 2021 | General | $297 | 4 | |
| 2020 | General | $128 | 4 | |
| 2019 | General | $1,146 | 16 |
Beside peers
- Rajesh Malik
- Neonatal-Perinatal Medicine median
- Middle half of Neonatal-Perinatal Medicine
- National median
In program year 2025, general payments to Rajesh Malik were reported at $728. Among 879 Neonatal-Perinatal Medicine profiles paid that year, the median was $77 and the middle half received between $26 and $145.
Show as a table
| Year | Rajesh Malik | Neonatal-Perinatal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,146 | $70 | $22–$125 | $163 |
| 2020 | $128 | $39 | $18–$108 | $114 |
| 2021 | $297 | $49 | $18–$122 | $132 |
| 2022 | $331 | $47 | $21–$149 | $149 |
| 2023 | $624 | $49 | $23–$140 | $160 |
| 2024 | $10,469 | $65 | $24–$132 | $164 |
| 2025 | $728 | $77 | $26–$145 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
12
Drug cost
$13,934
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 12 | $13,934 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.
Records
67 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neonatal-Perinatal Medicine in Ohio
Howard Stein
Neonatal-Perinatal Medicine · Toledo, OH
Brenda Poindexter
Neonatal-Perinatal Medicine · Cincinnati, OH
Jae Kim
Neonatal-Perinatal Medicine · Cincinnati, OH
Andrew South
Neonatal-Perinatal Medicine · Akron, OH
Pablo Sanchez
Neonatal-Perinatal Medicine · Columbus, OH
Hany Aly
Neonatal-Perinatal Medicine · Cleveland, OH
Related records
Neonatal-Perinatal Medicine in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Neonatal-Perinatal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.